A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy-Reference-Cited by-同舟云学术

A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy

Published:2020-09-03 Issue:11 Volume:35 Page:1957-1965
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Meissner Wassilios G.¹²³⁴^ORCID,Traon Anne Pavy‐Le⁵,Foubert‐Samier Alexandra¹⁶,Galabova Gergana⁷,Galitzky Monique⁸,Kutzelnigg Alexandra⁷,Laurens Brice¹,Lührs Petra⁷,Medori Rossella⁷,Péran Patrice⁹^ORCID,Sabatini Umberto¹⁰,Vergnet Sylvain¹,Volc Dieter¹¹,Poewe Werner¹²,Schneeberger Achim⁷,Staffler Günther⁷,Rascol Olivier¹³,Anheim Mathieu,Castrioto Anna,Derkinderen Pascal,Drapier Sophie,Eusebio Alexandra,Grabli David,Marques Ana,Moreau Caroline,Moro Elena,Tranchant Christine,

Affiliation:

1. Service de Neurologie, CRMR Atrophie Multisystématisée CHU Bordeaux Bordeaux France

2. Univ. de Bordeaux CNRS, IMN, UMR 5293 Bordeaux F‐33000 France

3. CNRS, IMN, UMR 5293 Bordeaux F‐33000 France

4. Dept. Medicine University of Otago, Christchurch, and New Zealand Brain Research Institute Christchurch New Zealand

5. Service de Neurologie, CRMR Atrophie Multisystématisée CHU Toulouse, Toulouse– INSERM U 1048 Institut des Maladies Métaboliques et Cardiovasculaires Toulouse France

6. INSERM U897, Public Health and Development Institute (ISPED) Bordeaux University Bordeaux France

7. AFFiRiS AG Vienna Austria

8. Clinical Investigation Center CIC1436, French Reference Centre for MSA University Hospital Toulouse, University Toulouse France

9. ToNIC, Toulouse NeuroImaging Center Université de Toulouse Toulouse France

10. Institute of Neuroradiology University Magna Graecia Catanzaro Italy

11. Study Center PROSENEX Ambulatorium Betriebs GesmbH at Confraternität‐Privatklinik Vienna Austria

12. Department of Neurology Medical University of Innsbruck Innsbruck Austria

13. Université de Toulouse 3, CHU de Toulouse, INSERM, Centre de Reference AMS, Service de Neurologie et de Pharmacologie Clinique Centre d'Investigation Clinique CIC1436, Réseau NS‐Park/FCRIN et Centre of Excellence for Neurodegenerative Disorders (COEN) de Toulouse Toulouse France

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28218

Reference19 articles.

1. Multiple-System Atrophy

2. Present and future of disease-modifying therapies in multiple system atrophy

3. Multiple System Atrophy: Recent Developments and Future Perspectives

4. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)

5. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on multiple system atrophy;Current Opinion in Neurology;2024-06-03

2. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond;Current Neuropharmacology;2024-05

3. Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?;Parkinsonism & Related Disorders;2024-05

4. Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disorders;Bioengineering & Translational Medicine;2024-04-09

5. Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials;Journal of Neurology;2024-03-14